Merit Medical [MMSI] vs Avantor [AVTR] Detailed Stock Comparison
Merit Medical
NASDAQ
Loading...
Avantor
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Merit Medical wins in 9 metrics, Avantor wins in 10 metrics, with 0 ties. Avantor appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Merit Medical | Avantor | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 43.44 | 11.27 | Avantor |
| Price-to-Book Ratio | 3.41 | 1.23 | Avantor |
| Debt-to-Equity Ratio | 55.14 | 67.49 | Merit Medical |
| PEG Ratio | 23.07 | 10.07 | Avantor |
| EV/EBITDA | 19.27 | 10.84 | Avantor |
| Profit Margin (TTM) | 8.31% | 10.31% | Avantor |
| Operating Margin (TTM) | 12.30% | 7.63% | Merit Medical |
| EBITDA Margin (TTM) | 12.30% | 7.63% | Merit Medical |
| Return on Equity | 8.60% | 11.73% | Avantor |
| Return on Assets (TTM) | 4.19% | 3.24% | Merit Medical |
| Free Cash Flow (TTM) | $182.76M | $692.00M | Avantor |
| 1-Year Return | -5.43% | -54.00% | Merit Medical |
| Price-to-Sales Ratio (TTM) | 3.54 | 1.16 | Avantor |
| Enterprise Value | $5.43B | $11.55B | Avantor |
| EV/Revenue Ratio | 3.79 | 1.73 | Avantor |
| Gross Profit Margin (TTM) | 48.24% | 32.92% | Merit Medical |
| Revenue per Share (TTM) | $24 | $10 | Merit Medical |
| Earnings per Share (Diluted) | $1.97 | $1.01 | Merit Medical |
| Beta (Stock Volatility) | 0.66 | 0.96 | Merit Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Merit Medical vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Merit Medical | -0.08% | 0.94% | -10.24% | -10.94% | -22.14% | -10.92% |
| Avantor | 1.05% | 1.23% | -16.36% | -6.35% | -39.51% | -45.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Merit Medical | -5.43% | 35.88% | 83.69% | 246.62% | 573.86% | 509.98% |
| Avantor | -54.00% | -59.77% | -44.44% | -20.76% | -20.76% | -20.76% |
Performance & Financial Health Analysis: Merit Medical vs Avantor
| Metric | MMSI | AVTR |
|---|---|---|
| Market Information | ||
| Market Cap | $5.07B | $7.76B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 710,905 | 19,256,440 |
| 90 Day Avg. Volume | 731,742 | 13,953,210 |
| Last Close | $85.58 | $11.50 |
| 52 Week Range | $81.04 - $111.45 | $10.82 - $27.83 |
| % from 52W High | -23.21% | -58.68% |
| All-Time High | $111.45 (Jan 27, 2025) | $44.37 (Sep 20, 2021) |
| % from All-Time High | -23.21% | -74.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | -0.01% |
| Quarterly Earnings Growth | -0.09% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.10% |
| Operating Margin (TTM) | 0.12% | 0.08% |
| Return on Equity (TTM) | 0.09% | 0.12% |
| Debt to Equity (MRQ) | 55.14 | 67.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $25.13 | $9.22 |
| Cash per Share (MRQ) | $5.77 | $0.66 |
| Operating Cash Flow (TTM) | $239.96M | $681.80M |
| Levered Free Cash Flow (TTM) | $190.72M | $688.84M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Merit Medical vs Avantor
| Metric | MMSI | AVTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 43.44 | 11.27 |
| Forward P/E | 23.07 | 10.07 |
| PEG Ratio | 23.07 | 10.07 |
| Price to Sales (TTM) | 3.54 | 1.16 |
| Price to Book (MRQ) | 3.41 | 1.23 |
| Market Capitalization | ||
| Market Capitalization | $5.07B | $7.76B |
| Enterprise Value | $5.43B | $11.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.79 | 1.73 |
| Enterprise to EBITDA | 19.27 | 10.84 |
| Risk & Other Metrics | ||
| Beta | 0.66 | 0.96 |
| Book Value per Share (MRQ) | $25.13 | $9.22 |
Financial Statements Comparison: Merit Medical vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MMSI | AVTR |
|---|---|---|
| Revenue/Sales | $355.35M | $1.58B |
| Cost of Goods Sold | $183.33M | $1.05B |
| Gross Profit | $172.02M | $534.90M |
| Research & Development | $22.48M | N/A |
| Operating Income (EBIT) | $42.06M | $147.40M |
| EBITDA | $77.83M | $230.80M |
| Pre-Tax Income | $37.96M | $85.70M |
| Income Tax | $7.81M | $21.20M |
| Net Income (Profit) | $30.15M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MMSI | AVTR |
|---|---|---|
| Cash & Equivalents | $395.53M | $315.70M |
| Total Current Assets | $958.64M | $2.28B |
| Total Current Liabilities | $196.82M | $2.03B |
| Long-Term Debt | $808.22M | $3.28B |
| Total Shareholders Equity | $1.43B | $6.10B |
| Retained Earnings | $725.69M | $2.27B |
| Property, Plant & Equipment | $432.99M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MMSI | AVTR |
|---|---|---|
| Operating Cash Flow | $57.24M | $86.60M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $19.05M | $81.30M |
| Debt Repayment | $0 | $-31.30M |
| Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
| Metric | MMSI | AVTR |
|---|---|---|
| Shares Short | 3.67M | 40.07M |
| Short Ratio | 6.49 | 3.41 |
| Short % of Float | 0.09% | 0.08% |
| Average Daily Volume (10 Day) | 710,905 | 19,256,440 |
| Average Daily Volume (90 Day) | 731,742 | 13,953,210 |
| Shares Outstanding | 58.74M | 680.80M |
| Float Shares | 57.82M | 664.21M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.09% | 1.00% |
Dividend Analysis & Yield Comparison: Merit Medical vs Avantor
| Metric | MMSI | AVTR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |